4.6 Article

Use of Complementary and Alternative Medicine (CAM) as Part of the Oncological Treatment: Survey about Patients' Attitude towards CAM in a University-Based Oncology Center in Germany

Journal

PLOS ONE
Volume 11, Issue 11, Pages -

Publisher

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0165801

Keywords

-

Ask authors/readers for more resources

Introduction To understand if and which patients would be open-minded to Complementary and Alternative Medicine (CAM) use parallel to their oncological treatment. Moreover, we sought to determine which methods are most accepted and which are the primary motivators to use CAM. Methods We developed and anonymously conducted a questionnaire for patients in the oncology center (TU Munich). Questions focus on different CAM methods, previous experiences, and willingness to apply or use CAM when offered in a university-based setting. Results A total of 171 of 376 patients (37.4% women, 62.0% men, 0.6% unknown) participated. This corresponds to a return rate of 45%. Median age was 64 years (17-87 years). Of all participants, 15.2% used CAM during their oncological therapy; 32.7% have used it in the past. The majority (81.9%) was not using CAM during therapy; 55.5% have not used CAM in the past respectively. The analysis revealed a significant correlation between education and CAM use during therapy (r = 0.18; p = 0.02), and CAM use in the past (r = 0.17; p = 0.04). Of all patients using CAM during therapy, favored methods were food supplements (42.3%), vitamins/minerals (42.3%), massage (34.6%). Motivations are especially the reduction of side effect and stress, the positive effect of certain CAM-treatments on the immune system and tumor therapy. Results showed no difference between women and men. Most patients not having had any experience with CAM complain about the deficiency of information by their treating oncologist (31.4%) as well as missing treatment possibilities (54.3%). Conclusion Since many patients believe in study results demonstrating the efficacy of CAM, it stresses our task to develop innovative study protocols to investigate the outcomes of certain CAM on symptom reduction or other endpoints. Thus, prospective trials and innovative evidence-based treatment concepts to include CAM into high-end oncology is what patients demand and what a modern oncology center should offer.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Dermatology

Is the humoral immunity dispensable for the pathogenesis of psoriasis?

J. Thomas, M. Kuepper, R. Batra, M. Jargosch, A. Atenhan, V. Baghin, L. Krause, F. Lauffer, T. Biedermann, F. J. Theis, K. Eyerich, S. Eyerich, N. Garzorz-Stark

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)

Letter Allergy

Recall urticaria-A new clinical sign in the diagnosis of alpha-gal syndrome

Paul Schmidle, Klara Reidenbach, Claudia Kugler, Bernadette Eberlein, Tilo Biedermann, Ulf Darsow

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)

Article Biology

Students' expectations in an international Master of Science course in radiation biology

Stephanie E. Combs, Carmen Kessel, Pascal O. Berberat, Michael J. Atkinson

INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2019)

Letter Dermatology

Unexpected photosensitivity - a patient with dermatomyositis and concomitant solar urticaria

K. Reidenbach, R. Mattjie, A. von Zumbusch, T. Biedermann, B. Eberlein

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)

Letter Allergy

Drugs of porcine origin-A risk for patients with α-gal syndrome?

Kyra Swiontek, Martine Morisset, Francoise Codreanu-Morel, Joerg Fischer, Jana Mehlich, Ulf Darsow, Nadine Petitpain, Tilo Biedermann, Markus Ollert, Bernadette Eberlein, Christiane Hilger

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE (2019)

Review Allergy

Birch pollen allergy in Europe

T. Biedermann, L. Winther, S. J. Till, P. Panzner, A. Knulst, E. Valovirta

ALLERGY (2019)

Review Allergy

Galactose α-1,3-galactose phenotypes Lessons from various patient populations

Michael Levin, Danijela Apostolovic, Tilo Biedermann, Scott P. Commins, Onyinye I. Iweala, Thomas A. E. Platts-Mills, Eleonora Savi, Marianne van Hage, Jeffrey M. Wilson

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY (2019)

Review Allergy

Role and Mechanism of Galactose-Alpha-1,3-Galactose in the Elicitation of Delayed Anaphylactic Reactions to Red Meat

Christiane Hilger, Joerg Fischer, Florian Woelbing, Tilo Biedermann

CURRENT ALLERGY AND ASTHMA REPORTS (2019)

Review Dermatology

Clinical features and management of superficial fibromatoses

Shinorik Kelenjian, Rebeca Assuncao Mattjie, Regina Franz, Tilo Biedermann, Knut Brockow

JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT (2019)

Editorial Material Allergy

Mast cells: Promoters of health and modulators of disease

Marcus Maurer, Martin Koeberle, Martin Metz, Tilo Biedermann

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2019)

Letter Dermatology

Pyoderma gangrenosum in a patient with lipoid proteinosis (Urbach-Wiethe disease)

A. C. Pilz, A. Zink, R. Franz, T. Biedermann, S. M. C. Moeckel

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)

Article Dermatology

Variable response to low-dose naltrexone in patients with Darier disease: a case series

D. Boehmer, K. Eyerich, U. Darsow, T. Biedermann, A. Zink

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)

Letter Dermatology

Understanding roofers' sun protection behaviour: a qualitative study

S. Ziehfreund, B. Schuster, T. Biedermann, A. Zink

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2019)

Article Oncology

Neoadjuvant stereotactic radiosurgery for intracerebral metastases of solid tumors (NepoMUC): a phase I dose escalation trial

Christian D. Diehl, Ehab Shiban, Christoph Straube, Jens Gempt, Jan J. Wilkens, Markus Oechsner, Carmen Kessel, Claus Zimmer, Benedict Wiestler, Bernhard Meyer, Stephanie E. Combs

CANCER COMMUNICATIONS (2019)

Article Biology

A Five-Year report on the conception and establishment of the MSc Radiation Biology at the Technical University of Munich

Carmen Kessel, Michael J. Atkinson, Thomas E. Schmid, Klaus Trott, Jan J. Wilkens, Natasa Anastasov, Michael Rosemann, Omid Azimzadeh, Soile Tapio, Simone Moertl, Ulrike M. Kulka, Michael Abend, Matthias Port, Christina Beinke, Mona Mustafa, Frauke Neff, Daniela Pfeiffer, Pascal Berberat, Stephanie E. Combs

Summary: The MSc Radiation Biology program has been evaluated over the last five years, showing a diverse student cohort with different nationalities and undergraduate backgrounds. Measures taken after regular quality meetings and student feedback have led to improvements in curriculum, workload, teacher training, and examination regulations.

INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2021)

No Data Available